Pricing and Reimbursement Series NICE its impact on the UK healthcare system and beyond

"IntroductionNICE is one of the most advanced cost effectiveness assessment bodies operating in the major pharmaceutical markets. Since it was established it has had an increasing impact on the availability of new drugs in England and Wales, but has also generated considerable attention globally.ScopeOverview of the UK pricing and reimbursement system and the role NICE plays in it Analysis of the key issues facing NICE and the measures being taken to rectify them Discussion of case studies to illustrate the effect of and response to key NICE rulingsHighlightsNICE plays a key role in the UK healthcare system although it does not currently assess all new drug approvals. It's impact is also felt outside the UK as organizations and indeed individual physicians in other countries also monitor its conclusions. A variety of stakeholders have input into the NICE topic selection process including patients, physicians and the pharmaceutical industry. To date cancer drugs have accounted for the largest number of completed assessments.Reasons to PurchaseUnderstand how NICE assessments impact the pricing and reimbursement environment in England and Wales Gain insight into the key issues with NICE assessments and the changes which are being used to tackle them Benchmark the impact and response to the outcome of key NICE assessments"

26-Sep-07 Format: PDF Pages: 50
Table fo Contents
Price: $3,800.00 / GBP1,900.00